14:13:49 EDT Tue 16 Jul 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Sedar documents are in PDF format and require Adobe Reader to view them.
You can also enable hit highlighting - Click here for instructions to enable this.

Sedar Search Results - 21 items
HitsSymIssuerDateType/IndustrySymSynopsis
0RLVRelevium Technologies Inc.2019-07-10News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-07-03News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-07-02News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-26News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-21Report of exempt distribution excluding Schedule 1 of 45-106F1
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-19News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-13News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-11News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-05News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-06-03News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-3052-109FV2 - Certification of interim filings - CFO (E)
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-3052-109FV2 - Certification of interim filings - CEO (E)
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-30MD&A - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-30Interim financial statements/report - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-30News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-24News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-21Early warning report
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-21Press release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-21News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-05-17News release - English
consumer products - biotechnology/pharmaceuticals
Document
0RLVRelevium Technologies Inc.2019-04-18Report of exempt distribution excluding Schedule 1 of 45-106F1
consumer products - biotechnology/pharmaceuticals
Document